Schiff G M, Rauh J L, Young B, Trimble S, Rotte T, Schiff B E
JAMA. 1978 Dec 8;240(24):2635-7. doi: 10.1001/jama.240.24.2635.
In a 7 1/2-year follow-up evaluation of the duration of rubella-vaccine-induced immunity of students who received either HPV-77 DK-12 or Cendehill vaccine, both groups showed a continous decline in hemagglutination-inhibition antibody from seven weeks after vaccination but a lower decline between 4 1/2 and 7 1/2 years after vaccination. However, at 7 1/2 years only 16 students (8%) receiving the Cendehill vaccine and one student (0.5%) receiving the HPV-77 DK-12 vaccine lacked detectable antibody. Despite the persistence of antibody titers, there was evidence of subclinical rubella among both groups of vaccinated students. These results emphasize the importance of continued evaluation of the conditions of persons receiving rubella vaccine.
在一项对接种HPV-77 DK-12或Cendehill风疹疫苗的学生进行的为期7年半的风疹疫苗诱导免疫持续时间的随访评估中,两组在接种疫苗7周后血凝抑制抗体均持续下降,但在接种疫苗4年半至7年半之间下降幅度较小。然而,在7年半时,仅16名接种Cendehill疫苗的学生(8%)和1名接种HPV-77 DK-12疫苗的学生(0.5%)缺乏可检测到的抗体。尽管抗体滴度持续存在,但两组接种疫苗的学生中均有亚临床风疹的证据。这些结果强调了持续评估接种风疹疫苗者状况的重要性。